Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide 99%Freeze-dried powder In stock Minimum Order Hot Selling
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - large image1
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image1
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image2
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image3
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image4
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image5
Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling buy - image6

Retatrutide 99%Freeze-dried powder In stock Minimum Order Hot Selling

TDS 6519 Inquiries

Unit Price:

$47/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Tianjin (CNTJ)

Brand:

Pharma;Conutrix

Packaging:

10 vials/box

Price valid (until):

2027-08-15

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,Cynomorium Songaricum Extract,Bull Penis Powder,Deer Penis Extract

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    Product Name Retatrutide
    Purity ≥98% (HPLC)
    Appearance White to off‑white lyophilized powder
    Storage −20°C, sealed, dry, avoid light
    Shelf Life 24 months under proper storage
    Quality Standard HPLC tested, complete COA provided


      Product Detail  


    RT Peptide (Retatrutide, short for Reta/GLP-3RT) is a new-generation metabolic regulatory peptide, mainly applied in weight loss and blood sugar regulation.

    1. Basic Molecular Parameters (Industry Standard)

    Full Name: Retatrutide

    Amino Acid Sequence: H-His¹-Gly²-Glu³-Gly⁴-Thr⁵-Phe⁶-Thr⁷-Ser⁸-Asp⁹-Lys¹⁰(PEG27)-Ala¹¹-Gln¹²-Thr¹³-Phe¹⁴-Val¹⁵-Gly¹⁶-Glu¹⁷-Gly¹⁸-Pro¹⁹-Ser²⁰-Ser²¹-Gly²²-Ala²³-Pro²⁴-Pro²⁵-Ser²⁶-Lys²⁷-OH

    Molecular Formula: C₁₉₁H₂₉₇N₅₅O₆₇S

    Molecular Weight: ~4633 g/mol

    CAS Number: 2787973-52-9

    Appearance: Sterile lyophilized white/off-white powder, vial packaging (common specs: 5mg / 10mg per vial)

    Purity: ≥98.0% tested by HPLC; each batch is attached with full COA, HPLC chromatogram and MSDS

    R&D Background: Retatrutide is a novel triple receptor agonist targeting GLP‑1R, GIPR and GCGR, developed for metabolic disorder preclinical research. It is a long-acting PEGylated synthetic peptide with balanced activation of three key metabolic hormone receptors.

    2. Core Mechanism of Action

    Retatrutide is a balanced triple agonist of GLP‑1, GIP and glucagon receptors, regulating multi-organ metabolic pathways simultaneously:
    • Activate GLP‑1R to suppress appetite, slow gastric emptying and reduce caloric intake; improve insulin secretion in a glucose-dependent manner;
    • Stimulate GIPR to enhance pancreatic β-cell function, boost insulin sensitivity and reduce hepatic glucose output;
    • Moderately activate GCGR to increase energy expenditure via hepatic fat oxidation and lipolysis;
    • Reduce visceral adipose tissue accumulation by inhibiting adipocyte differentiation;
    • Lower circulating triglycerides, LDL and liver lipid deposition to alleviate hepatic steatosis;
    • Regulate central hypothalamic appetite circuits for sustained weight-lowering effects.

    3. Core Research Efficacy (For Laboratory Research Only)

    Weight Management & Obesity Research

    Induce significant, sustained body weight loss in obese animal models; ideal reagent for studies on adiposity, fat metabolism and anti-obesity drug screening.

    Type 2 Diabetes & Insulin Resistance

    Stabilize blood glucose levels, improve HbA1c and peripheral insulin sensitivity; widely applied in diabetic rodent cell & animal experimental models.

    Non-Alcoholic Fatty Liver Disease (NAFLD)

    Reduce hepatic lipid buildup, relieve hepatic steatosis and hepatic inflammation; support research on metabolic liver injury repair.

    Cardiometabolic Risk Improvement

    Lower blood lipid levels and alleviate metabolic-related vascular dysfunction; used for preclinical research on metabolic cardiovascular complications.

    Compliance Disclaimer

    This product is for laboratory research use only. It shall not be used for human injection, oral administration or clinical medical treatment. All descriptions are based on preclinical experimental data and do not constitute therapeutic medical claims.


      About us  


              Anhui Ruibang Trading Co., Ltd. was established with a clear mission: to simplify international trade for businesses of all sizes. We act as a bridge between manufacturers and global buyers, offering professional sourcing, quality inspection, order coordination, and logistics management.

             Our team brings years of experience in cross-border trade, supplier networks, and export documentation. We understand the challenges of international business — language barriers, quality control, shipping complexities — and we solve them with a client-first approach.
           At Ruibang Trading, we don’t just move goods; we build relationships. Whether you are looking for a reliable supplier, need help consolidating shipments, or want to expand your product line, we provide tailored solutions to meet your goals.
             Our Commitment: Integrity, efficiency, and transparency in every transaction.


      Why choose us  


    Our products are of reliable quality and sell well all over the world, with partners across many countries and regions. We have professional technical support and complete after-sales teams to promptly respond to all your inquiries and demands.

               We always strictly control product quality, adhere to honest business principles, and prioritize quality and service. With stable product strength and thoughtful services, we sincerely welcome global customers to negotiate cooperation and achieve win-win development together.

               We have been deeply engaged in the peptide industry for many years, serving as a source biotechnology factory integrating R&D, synthesis, production and sales.

              We strictly follow production and quality control standards, with the whole process adopting aseptic production and independent lyophilization and packaging. Our products feature stable appearance, good solubility and high activity retention.

              We support trial orders with small quantities, bulk orders and customized formulas, providing one-stop solutions for foreign trade supply and private customization needs.


    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 1

    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 2

    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 3

    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 4


     

      Our Advantages

     


    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 5


     

      Packaging Process:  

     


    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 6

    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 7
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 8
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 9
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 10
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 11
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 12
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 13
    Shop Retatrutide 99%Freeze-dried powder  In stock Minimum Order Hot Selling-Detailed Image 14
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,Cynomorium Songaricum Extract,Bull Penis Powder,Deer Penis Extract

    Location:

    Hefei, Provincia de Anhui

    Year of Establishment:

    2026

  • Inquiry History
    6519 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.